Patient Pathfinder: Clinical Trials
Clinical Trials for Prostate Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 791 active Prostate Cancer trials
Non-Invasive Biomarkers in Prostate Cancer Disease Management
Study Type: Observational
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
Study Type: Interventional Phase 2
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Study Type: Interventional Phase 1
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer
Study Type: Interventional Phase 1
A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.
Study Type: Interventional Phase 1
A Study to Investigate the Biological Effects of AZD5305, Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.
Study Type: Interventional Phase 1
Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy
Study Type: Observational
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Study Type: Interventional Phase 2
There are 791 active Prostate Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now